These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1399740)

  • 1. Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents.
    Britten RA; Green JA; Warenius HM
    Int J Radiat Oncol Biol Phys; 1992; 24(3):527-31. PubMed ID: 1399740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.
    van der Zee AG; van Ommen B; Meijer C; Hollema H; van Bladeren PJ; de Vries EG
    Br J Cancer; 1992 Nov; 66(5):930-6. PubMed ID: 1419639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.
    Cheng X; Kigawa J; Minagawa Y; Kanamori Y; Itamochi H; Okada M; Terakawa N
    Cancer; 1997 Feb; 79(3):521-7. PubMed ID: 9028363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer.
    Kigawa J; Minagawa Y; Kanamori Y; Itamochi H; Cheng X; Okada M; Oishi T; Terakawa N
    Cancer; 1998 Feb; 82(4):697-702. PubMed ID: 9477102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
    Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expression of glutathione S-transferase pi in human ovarian cancer as an indicator of resistance to chemotherapy].
    Li L; Yao D; Chen X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):95-7. PubMed ID: 10682429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells.
    Chen G; Waxman DJ
    Biochem Pharmacol; 1994 Mar; 47(6):1079-87. PubMed ID: 8147907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
    Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
    Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase mu.
    Horton JK; Roy G; Piper JT; Van Houten B; Awasthi YC; Mitra S; Alaoui-Jamali MA; Boldogh I; Singhal SS
    Biochem Pharmacol; 1999 Aug; 58(4):693-702. PubMed ID: 10413308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of glutathione S-transferase mu expression in ovarian tumors.
    Matsumoto T; Hayase R; Kodama J; Kamimura S; Yoshinouchi M; Kudo T
    Eur J Obstet Gynecol Reprod Biol; 1997 Jun; 73(2):171-6. PubMed ID: 9228500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
    Mistry P; Kelland LR; Abel G; Sidhar S; Harrap KR
    Br J Cancer; 1991 Aug; 64(2):215-20. PubMed ID: 1892748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoresistance in rat ovarian tumours.
    Zeller WJ; Frühauf S; Chen G; Keppler BK; Frei E; Kaufmann M
    Eur J Cancer; 1991; 27(1):62-7. PubMed ID: 1826445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-transit melanoma: the role of alkylating-agent resistance in regional therapy.
    Grubbs EG; Abdel-Wahab O; Cheng TY; Abdel-Wahab Z; Peterson B; Pruitt SK; Colvin OM; Friedman HS; Tyler DS
    J Am Coll Surg; 2004 Sep; 199(3):419-27. PubMed ID: 15325612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of glutathione S-transferase pi (GST-pi) and chemotherapy response in malignant ovarian tumors.
    Hirazono K; Shinozuka T; Kuroshima Y; Itoh H; Kawai K
    J Obstet Gynaecol (Tokyo 1995); 1995 Jun; 21(3):305-12. PubMed ID: 8590371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
    Ozols RF; Louie KG; Plowman J; Behrens BC; Fine RL; Dykes D; Hamilton TC
    Biochem Pharmacol; 1987 Jan; 36(1):147-53. PubMed ID: 3801051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
    Dirven HA; van Ommen B; van Bladeren PJ
    Cancer Res; 1994 Dec; 54(23):6215-20. PubMed ID: 7954469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione-S-transferase activity and isoenzyme levels measured by two methods in ovarian cancer, and their value as markers of disease outcome.
    Wrigley EC; McGown AT; Buckley H; Hall A; Crowther D
    Br J Cancer; 1996 Mar; 73(6):763-9. PubMed ID: 8611377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione and glutathione S-transferases as early markers for ovarian carcinomas: case series.
    Sprem M; Babić D; Abramić M; Vrhovec I; Skrk J; Milicić D; Ambriović Ristov A; Kalafatić D; Osmak M
    Croat Med J; 2001 Dec; 42(6):624-9. PubMed ID: 11740844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione S-transferase expression in benign and malignant ovarian tumours.
    Green JA; Robertson LJ; Clark AH
    Br J Cancer; 1993 Aug; 68(2):235-9. PubMed ID: 8347477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancer.
    Tanner B; Hengstler JG; Dietrich B; Henrich M; Steinberg P; Weikel W; Meinert R; Kaina B; Oesch F; Knapstein PG
    Gynecol Oncol; 1997 Apr; 65(1):54-62. PubMed ID: 9103391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.